-
1
-
-
0034483915
-
LPS: Another piece in the puzzle
-
discussion 301-292 •• Comprehensive guide to endotoxin structure, characterization and inflammatory properties.
-
Vogel SN. LPS: another piece in the puzzle. J. Endotoxin Res. 6, 295-300; discussion 301-292 (2000). •• Comprehensive guide to endotoxin structure, characterization and inflammatory properties.
-
(2000)
J. Endotoxin Res.
, vol.6
, pp. 295-300
-
-
Vogel, S.N.1
-
2
-
-
84857792409
-
Sepsis, thrombosis and organ dysfunction
-
Semeraro N, Ammollo CT, Semeraro F et al. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 129, 290-295 (2012).
-
(2012)
Thromb. Res.
, vol.129
, pp. 290-295
-
-
Semeraro, N.1
Ammollo, C.T.2
Semeraro, F.3
-
3
-
-
0027252052
-
Microbial cell-wall contaminants in peptides: A potential source of physiological artifacts
-
•• Good review of the translational challenges for theraputics due to endotoxin contamination.
-
Majde JA. Microbial cell-wall contaminants in peptides: a potential source of physiological artifacts. Peptides 14, 629-632 (1993). •• Good review of the translational challenges for theraputics due to endotoxin contamination.
-
(1993)
Peptides
, vol.14
, pp. 629-632
-
-
Majde, J.A.1
-
4
-
-
34848921824
-
Methods of endotoxin removal from biological preparations: A review
-
Magalhaes PO, Lopes AM, Mazzola PG et al. Methods of endotoxin removal from biological preparations: a review. J. Pharm. Pharm. Sci. 10, 388-404 (2007).
-
(2007)
J. Pharm. Pharm. Sci.
, vol.10
, pp. 388-404
-
-
Magalhaes, P.O.1
Lopes, A.M.2
Mazzola, P.G.3
-
5
-
-
9244221699
-
Characterization of the DialGuard device for endotoxin removal in hemodialysis
-
Szathmary S, Hegyi E, Amoureux MC et al. Characterization of the DialGuard device for endotoxin removal in hemodialysis. Blood Purif. 22, 409-415 (2004).
-
(2004)
Blood Purif.
, vol.22
, pp. 409-415
-
-
Szathmary, S.1
Hegyi, E.2
Amoureux, M.C.3
-
10
-
-
79952278110
-
Nanotechnology for delivery of drugs and biomedical applications
-
Leucuta SE. Nanotechnology for delivery of drugs and biomedical applications. Curr. Clin. Pharmacol. 5, 257-280 (2010).
-
(2010)
Curr. Clin. Pharmacol.
, vol.5
, pp. 257-280
-
-
Leucuta, S.E.1
-
11
-
-
84908223791
-
Immunotoxicity testing for drug-nanoparticle conjugates: Regulatory considerations
-
Bancos S, Tyner KM, Weaver JL. Immunotoxicity testing for drug-nanoparticle conjugates: regulatory considerations. Front. Nanobiomed. Res. 1, 671-683 (2012).
-
(2012)
Front. Nanobiomed. Res.
, vol.1
, pp. 671-683
-
-
Bancos, S.1
Tyner, K.M.2
Weaver, J.L.3
-
12
-
-
84887089130
-
Nanoparticles and endotoxin
-
•• Provides a comprehensive overview of endotoxin-mediated inflammatory properties of nanomaterials and describes challenges with endotoxin detection in nanoformulations
-
Dobrovolskaia MA. McNeil SE. Nanoparticles and endotoxin. Front. Nanobiomed. Res. 1, 77-110 (2012). •• Provides a comprehensive overview of endotoxin-mediated inflammatory properties of nanomaterials and describes challenges with endotoxin detection in nanoformulations.
-
(2012)
Front. Nanobiomed. Res.
, vol.1
, pp. 77-110
-
-
Ma, D.1
McNeil, S.E.2
-
13
-
-
77953379662
-
Ambiguities in applying traditional limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations
-
•• Describes case studies demonstrating nanoparticle interference with limulus amoebocyte lysate (LAL) assays
-
Dobrovolskaia MA, Neun BW, Clogston JD et al. Ambiguities in applying traditional limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations. Nanomedicine (Lond.) 5, 555-562 (2010). •• Describes case studies demonstrating nanoparticle interference with limulus amoebocyte lysate (LAL) assays.
-
(2010)
Nanomedicine (Lond.)
, vol.5
, pp. 555-562
-
-
Dobrovolskaia, M.A.1
Neun, B.W.2
Clogston, J.D.3
-
14
-
-
67651205441
-
Evaluation of nanoparticle immunotoxicity
-
• Describes the decision tree for selection of appropriate LAL formats for nanomaterials
-
Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat. Nanotechnol. 4, 411-414 (2009). • Describes the decision tree for selection of appropriate LAL formats for nanomaterials.
-
(2009)
Nat. Nanotechnol.
, vol.4
, pp. 411-414
-
-
Dobrovolskaia, M.A.1
Germolec, D.R.2
Weaver, J.L.3
-
15
-
-
0034793693
-
Interference in the limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis
-
Bohrer D, Horner R, do Nascimento PC et al. Interference in the limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis. J. Pharm. Biomed. Anal. 26, 811-818 (2001).
-
(2001)
J. Pharm. Biomed. Anal.
, vol.26
, pp. 811-818
-
-
Bohrer, D.1
Horner, R.2
Do Nascimento, P.C.3
-
16
-
-
0025271604
-
Resolving LAL test interferences
-
•• Describes examples of LAL interferences and ways to overcome them
-
Cooper JF. Resolving LAL test interferences. J. Parenter. Sci. Technol. 44, 13-15 (1990). •• Describes examples of LAL interferences and ways to overcome them.
-
(1990)
J. Parenter. Sci. Technol.
, vol.44
, pp. 13-15
-
-
Cooper, J.F.1
-
17
-
-
0030744865
-
The impact of nonendotoxin LAL-reactive materials on limulus amebocyte lysate analyses
-
Cooper JF, Weary ME, Jordan FT. The impact of nonendotoxin LAL-reactive materials on limulus amebocyte lysate analyses. PDA J. Pharm. Sci. Technol. 51, 2-6 (1997).
-
(1997)
PDA J. Pharm. Sci. Technol.
, vol.51
, pp. 2-6
-
-
Cooper, J.F.1
Weary, M.E.2
Jordan, F.T.3
-
18
-
-
78650302442
-
Saline and buffers minimize the action of interfering factors in the bacterial endotoxins test
-
Fujita Y, Tokunaga T, Kataoka H. Saline and buffers minimize the action of interfering factors in the bacterial endotoxins test. Anal. Biochem. 409, 46-53 (2011).
-
(2011)
Anal. Biochem.
, vol.409
, pp. 46-53
-
-
Fujita, Y.1
Tokunaga, T.2
Kataoka, H.3
-
19
-
-
0034910369
-
Interfering effect of diphtheria-tetanus-acellular pertussis combined (DTaP) vaccines on the bacterial endotoxin test
-
Ochiai M, Yamamoto A, Kataoka M et al. Interfering effect of diphtheria-tetanus-acellular pertussis combined (DTaP) vaccines on the bacterial endotoxin test. Biologicals 29, 55-58 (2001).
-
(2001)
Biologicals
, vol.29
, pp. 55-58
-
-
Ochiai, M.1
Yamamoto, A.2
Kataoka, M.3
-
20
-
-
84868573583
-
Contamination of nanoparticles by endotoxin: Evaluation of different test methods
-
• Describes TLR4 reporter cell line as an alternative method for endotoxin detection in nanoparticles
-
Smulders S, Kaiser JP, Zuin S et al. Contamination of nanoparticles by endotoxin: evaluation of different test methods. Part Fibre Toxicol. 9, 41 (2012). • Describes TLR4 reporter cell line as an alternative method for endotoxin detection in nanoparticles.
-
Part Fibre Toxicol.
, vol.9
, Issue.41
, pp. 2012
-
-
Smulders, S.1
Kaiser, J.P.2
Zuin, S.3
-
22
-
-
20244375715
-
International validation of novel pyrogen tests based on human monocytoid cells
-
•• Describes the macrophage activation test as an alternative to LAL for detection and quantification of endotoxin
-
Hoffmann S, Peterbauer A, Schindler S et al. International validation of novel pyrogen tests based on human monocytoid cells. J. Immunol. Methods 298, 161-173 (2005). •• Describes the macrophage activation test as an alternative to LAL for detection and quantification of endotoxin.
-
(2005)
J. Immunol. Methods
, vol.298
, pp. 161-173
-
-
Hoffmann, S.1
Peterbauer, A.2
Schindler, S.3
-
24
-
-
85009662538
-
Immunotoxicity testing for drug-nanoparticle conjugates: Regulatory considerations
-
World Scientific Publishing Company, Singapore, •• Good overview of regulatory documents for nanoparticle immunotoxicity screening
-
Bancos S, Tyner KM, Weaver JL. Immunotoxicity testing for drug-nanoparticle conjugates: regulatory considerations. In: Handbook Immunological Properties of Engineered Nanomaterials. World Scientific Publishing Company, Singapore, 1, 671-685 (2013). •• Good overview of regulatory documents for nanoparticle immunotoxicity screening.
-
(2013)
Handbook Immunological Properties of Engineered Nanomaterials
, vol.1
, pp. 671-685
-
-
Bancos, S.1
Tyner, K.M.2
Weaver, J.L.3
-
26
-
-
77952696846
-
A physical and chemical stability study of amphotericin B lipid complexes (Abelcet) after dilution in dextrose 5%
-
Vanneaux V, Proust V, Chéron M et al. A physical and chemical stability study of amphotericin B lipid complexes (Abelcet) after dilution in dextrose 5%. EJHP Science 1, 10-13 (2007).
-
(2007)
EJHP Science
, vol.1
, pp. 10-13
-
-
Vanneaux, V.1
Proust, V.2
Chéron, M.3
-
27
-
-
0345241187
-
Detection of lipopolysaccharide in hemoglobin-vesicles by limulus amebocyte lysate test with kinetic-turbidimetric gel clotting analysis and pretreatment of surfactant
-
Sakai H, Hisamoto S, Fukutomi I et al. Detection of lipopolysaccharide in hemoglobin-vesicles by limulus amebocyte lysate test with kinetic-turbidimetric gel clotting analysis and pretreatment of surfactant. J. Pharm. Sci. 93, 310-321 (2004).
-
(2004)
J. Pharm. Sci.
, vol.93
, pp. 310-321
-
-
Sakai, H.1
Hisamoto, S.2
Fukutomi, I.3
-
28
-
-
0031213778
-
The release and detection of endotoxin from liposomes
-
Harmon P, Cabral-Lilly D, Reed RA et al. The release and detection of endotoxin from liposomes. Anal. Biochem. 250, 139-146 (1997).
-
(1997)
Anal. Biochem.
, vol.250
, pp. 139-146
-
-
Harmon, P.1
Cabral-Lilly, D.2
Reed, R.A.3
-
29
-
-
0026900858
-
Endotoxin detection
-
•• Describes differences between lipopolysaccharide and endotoxin and experimental ways of distinguishing biological activity of lipopolysaccharide versus endotoxin
-
Majde JA. Endotoxin detection. Immunol. Today 13, 328-329 (1992). •• Describes differences between lipopolysaccharide and endotoxin and experimental ways of distinguishing biological activity of lipopolysaccharide versus endotoxin.
-
(1992)
Immunol. Today
, vol.13
, pp. 328-329
-
-
Majde, J.A.1
|